Literature DB >> 11096725

Metastatic Disease of the Nervous System.

.   

Abstract

Nervous system metastases occur in about 25% of patients with systemic cancer (Table 1) and usually involve the brain parenchyma, leptomeninges, and spinal epidural space. Although they are ominous, they can be effectively treated in many patients, reducing disability and prolonging life. Treatment may include surgery, and radiation therapy and chemotherapy are often necessary. The choice of agents is often made on the basis of the primary tumor. Even when sustained remission cannot be achieved, effective palliation can be accomplished in most patients.

Entities:  

Year:  1999        PMID: 11096725     DOI: 10.1007/s11940-996-0004-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  13 in total

1.  High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

Authors:  M J Glantz; B F Cole; L Recht; W Akerley; P Mills; S Saris; F Hochberg; P Calabresi; M J Egorin
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

2.  Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium.

Authors:  M R Fetell; S A Grossman; J D Fisher; B Erlanger; E Rowinsky; J Stockel; S Piantadosi
Journal:  J Clin Oncol       Date:  1997-09       Impact factor: 44.544

3.  Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel.

Authors:  R J Freilich; A D Seidman; L M DeAngelis
Journal:  Cancer       Date:  1995-07-15       Impact factor: 6.860

4.  A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors.

Authors:  M J Glantz; B F Cole; M H Friedberg; E Lathi; H Choy; K Furie; W Akerley; L Wahlberg; A Lekos; S Louis
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

5.  Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?

Authors:  C J Vecht; H Haaxma-Reiche; E M Noordijk; G W Padberg; J H Voormolen; F H Hoekstra; J T Tans; N Lambooij; J A Metsaars; A R Wattendorff
Journal:  Ann Neurol       Date:  1993-06       Impact factor: 10.422

6.  Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis.

Authors:  R J Freilich; G Krol; L M DeAngelis
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

7.  Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma.

Authors:  E T Wong; C S Portlock; J P O'Brien; L M DeAngelis
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

Review 8.  The role of chemotherapy in the treatment of patients with brain metastases from solid tumors.

Authors:  J C Buckner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

9.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

Authors:  R A Patchell; P A Tibbs; W F Regine; R J Dempsey; M Mohiuddin; R J Kryscio; W R Markesbery; K A Foon; B Young
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

Review 10.  Management of brain metastases.

Authors:  L M DeAngelis
Journal:  Cancer Invest       Date:  1994       Impact factor: 2.176

View more
  1 in total

1.  Update in palliative management of hormone refractory cancer of prostate.

Authors:  Pratipal Singh; Aneesh Srivastava
Journal:  Indian J Urol       Date:  2007-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.